Glenmark Pharmaceuticals Nigeria, a subsidiary of Glenmark Pharmaceuticals, a global and fully integrated pharmaceutical company headquartered at Mumbai, India plans for expanding presence in the Nigerian market.

Glenmark Pharmaceuticals Nigeria, a subsidiary of Glenmark Pharmaceuticals, a global and fully integrated pharmaceutical company headquartered at Mumbai, India plans for expanding presence in the Nigerian market. Nigeria is the biggest market in West Africa and Glenmark has established its presence there in a very short span of time. The company plans  to double our business in 2008-09 and meet the $10 million mark by 2012-13.

At present Glenmark has 14 SKU registered in 12 months, and plans to have another six new products in Nigeria. In addition, Glenmark also has plans to substantially increase its team in Nigeria in the coming fiscal, and increase the presence of local talent in its sales and marketing team. Glenmark one of the leading players in the Indian branded generics market, specifically in areas of dermatology and respiratory started its Nigerian operations in April 2007 and has created a market for its products expecting sales of $ 1.3 million by the end of this fiscal. Currently in Nigeria, it is present in the areas of Dermatology/Gynaecology, Anti-infectives and Gastroenterology; and plans to additionally launch its products in the areas of Respiratory, Oncology and Metabolic diseases.